American Diabetes Association Pathway to Stop Diabetes 2018
|To:||Chairs and Administrators, Departments in the Biological & Physical Sciences; Associate Deans for Research; College/School Research Administrators|
|From:||Office of the Vice Chancellor for Research & Graduate Education|
|Date:||February 16, 2018|
|Subject:||American Diabetes Association Pathway to Stop Diabetes 2018|
|Deadline for Internal Review:||April 09, 2018|
The American Diabetes Associate invites institutional nominations of promising investigators with a high likelihood of making seminal contributions in diabetes research.
Pathway to Stop Diabetes accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication. Pathway solicits nominations for candidates in all disciplines as applied to diabetes, from medicine, biology and chemistry to engineering, mathematics and physics.
Amount per Award: Up to $1.625 million Dependent on program
Duration of Award: 5 – 7 Years Dependent on program
Number of Awards: 6 Awards
UW-Madison is allowed one nomination in total. The nomination can be in one of the three available Pathway award types:
Initiator Award (for researchers in postdoctoral training)
Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Accelerator Award (for early-career diabetes investigators)
Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for, or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Visionary Award (for established investigators, new to diabetes)
Supports established, experienced investigators with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. Applicants must hold established faculty positions and have demonstrated significant productivity in their current field of research. Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetes or diabetes-related research.
Internal Competition Application Instructions
Applications for Internal Review
To submit your application, follow this link: https://inic-uwmadison.fluidreview.com/
Please include the following information:
1) Cover Page
3) Abstract (250-word limit)
The abstract must not exceed 250 words. The abstract must be a description of the research strategy(ies), including scientific question(s) and approach(es) and should specifically highlight the relevance to a cure, prevention, and/or treatment of diabetes. The abstract should be written in the third person.
4) Research Strategy (2-3 pages) providing a description of the proposed project addressing the intent of the program solicitation.
Applications are due to ADA by July 02, 2018.